Beleva

January 15, 2010 – The U.S. Food and Drug Administration announced today stunning results from tests on Beleva, the much-heralded “wonder drug” destined to revolutionize human health worldwide and reduce U.S. healthcare costs alone by an estimated $1.2 trillion annually.

Five years of rigorous clinical trials have conclusively demonstrated that taking Beleva orally prevents most cancers, controls appetite, reduces body fat, aids circulation, promotes restful sleep, eliminates joint and back pain, increases energy and sexual drive, optimizes blood pressure, cures depression and other serious mental disorders, improves mood, increases bone density and cures the common cold, among other things.

Believe it! Say goodbye to rising health care costs. Get The Drift for the complete story.

Stay up to date with Vitalyst

Receive our monthly e-newsletter, Spark News, to learn about upcoming events, catalyst programs, and ways to get involved.